Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Spectrum Cannabis Colombia, now operating under the Spectrum Therapeutics brand, is the Colombian subsidiary of Canopy Growth Corporation focused on the production and distribution of medical cannabis. The company operates a large-scale cultivation and processing facility in Huila, Colombia, designed to produce high-quality, low-cost cannabinoid isolates and finished medical products for domestic and international markets. Its business model integrates federally licensed cultivation, extraction, and R&D to provide standardized medical cannabis oils and softgels to patients. As part of the global Spectrum Therapeutics network, the company emphasizes physician education and clinical research to validate cannabis-based therapies for conditions such as chronic pain and neurological disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Spectrum Cannabis Colombia.